Pharmaceutical formulation of valsartan

Details for Australian Patent Application No. 2008311053 (hide)

Owner Novartis AG

Inventors Wen, Hong; Talamonti, Wayne; Wagner, Robert Frank

Agent Davies Collison Cave

Pub. Number AU-B-2008311053

PCT Pub. Number WO2009/048848

Priority 60/978,531 09.10.07 US

Filing date 7 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 30 August 2012

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/048848 Priority application(s): WO2009/048848

30 August 2012 Application Accepted

  Published as AU-B-2008311053

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008311054-Sterilised dialysis solutions containing pyrophosphates

2008311052-Methods and compositions for high yielding soybeans with nematode resistance